Michael G. Brattain - Publications

Affiliations: 
Microbiology and Immunology State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Molecular Biology

221 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Leiphrakpam PD, Lazenby AJ, Smith LM, Brattain MG, Are C. Stathmin expression in metastatic colorectal cancer. Journal of Surgical Oncology. PMID 33765336 DOI: 10.1002/jso.26464  0.56
2020 Leiphrakpam PD, Lazenby AJ, Smith LM, Brattain MG, Black JD, Wang J, Are C. Correlation of PRL3 expression with colorectal cancer progression. Journal of Surgical Oncology. PMID 33179291 DOI: 10.1002/jso.26253  0.56
2020 Robb CM, Kour S, Contreras JI, Agarwal E, Barger CJ, Rana S, Sonawane Y, Neilsen BK, Taylor M, Kizhake S, Thakare RN, Chowdhury S, Wang J, Black JD, Hollingsworth MA, ... Brattain MG, et al. Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 11: 2462-2463. PMID 32637035 DOI: 10.18632/Oncotarget.27403  0.48
2019 Leiphrakpam PD, Lazenby AJ, Chowdhury S, Smith LM, Mathiesen M, Brattain MG, Wang J, Black JD, Are C. Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer. Journal of Surgical Oncology. PMID 31867736 DOI: 10.1002/jso.25805  0.56
2019 Laschanzky RS, Humphrey LE, Ma J, Smith LM, Enke TJ, Shukla SK, Dasgupta A, Singh PK, Howell GM, Brattain MG, Ly QP, Black AR, Black JD. Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy. Cancers. 11. PMID 31500290 DOI: 10.3390/cancers11091327  0.56
2018 Leiphrakpam PD, Brattain MG, Black JD, Wang JJ. TGFβ and IGF1R signaling activate protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells. The Journal of Biological Chemistry. PMID 29599290 DOI: 10.1074/jbc.RA117.001299  0.32
2018 Robb CM, Kour S, Contreras JI, Agarwal E, Barger CJ, Rana S, Sonawane Y, Neilsen BK, Taylor M, Kizhake S, Thakare RN, Chowdhury S, Wang J, Black JD, Hollingsworth MA, ... Brattain MG, et al. Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9: 5216-5232. PMID 29435174 DOI: 10.18632/Oncotarget.23749  0.48
2017 Bailey KL, Agarwal E, Chowdhury S, Luo J, Brattain MG, Black JD, Wang J. TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells. Plos One. 12: e0176096. PMID 28414818 DOI: 10.1371/journal.pone.0176096  0.48
2017 Agarwal E, Robb CM, Smith LM, Brattain MG, Wang J, Black JD, Chowdhury S. Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis. Oncogene. PMID 28068324 DOI: 10.1038/onc.2016.460  0.48
2015 Fisher KW, Das B, Kim HS, Clymer BK, Gehring D, Smith D, Costanzo-Garvey D, Fernandez M, Brattain MG, Kelly D, MacMillan J, White MA, Lewis RE. AMPK promotes aberrant PGC1β expression to support human colon tumor cell survival. Molecular and Cellular Biology. PMID 26351140 DOI: 10.1128/Mcb.00528-15  1
2014 Agarwal E, Chaudhuri A, Leiphrakpam PD, Haferbier KL, Brattain MG, Chowdhury S. Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer. Bmc Cancer. 14: 145. PMID 24581231 DOI: 10.1186/1471-2407-14-145  1
2014 Leiphrakpam PD, Rajput A, Mathiesen M, Agarwal E, Lazenby AJ, Are C, Brattain MG, Chowdhury S. Ezrin expression and cell survival regulation in colorectal cancer. Cellular Signalling. 26: 868-79. PMID 24462708 DOI: 10.1016/j.cellsig.2014.01.014  1
2014 Geng L, Chaudhuri A, Talmon G, Wisecarver JL, Are C, Brattain M, Wang J. MicroRNA-192 suppresses liver metastasis of colon cancer. Oncogene. 33: 5332-40. PMID 24213572 DOI: 10.1038/onc.2013.478  0.56
2014 Leiphrakpam PD, Agarwal E, Mathiesen M, Haferbier KL, Brattain MG, Chowdhury S. In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer. Oncology Reports. 31: 87-94. PMID 24173770 DOI: 10.3892/or.2013.2819  1
2013 Rajput A, Agarwal E, Leiphrakpam P, Brattain MG, Chowdhury S. Establishment and Validation of an Orthotopic Metastatic Mouse Model of Colorectal Cancer. Isrn Hepatology. 2013: 206875. PMID 27340651 DOI: 10.1155/2013/206875  0.48
2013 Hedrick ED, Agarwal E, Leiphrakpam PD, Haferbier KL, Brattain MG, Chowdhury S. Differential PKA activation and AKAP association determines cell fate in cancer cells. Journal of Molecular Signaling. 8: 10. PMID 24083380 DOI: 10.1186/1750-2187-8-10  1
2013 Zou Y, Howell GM, Humphrey LE, Wang J, Brattain MG. Ron knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi). Plos One. 8: e69992. PMID 23922886 DOI: 10.1371/Journal.Pone.0069992  1
2013 Chowdhury S, Ongchin M, Wan G, Sharratt E, Brattain MG, Rajput A. Restoration of PTEN activity decreases metastases in an orthotopic model of colon cancer. The Journal of Surgical Research. 184: 755-60. PMID 23623571 DOI: 10.1016/j.jss.2013.03.035  1
2013 Agarwal E, Brattain MG, Chowdhury S. Cell survival and metastasis regulation by Akt signaling in colorectal cancer. Cellular Signalling. 25: 1711-9. PMID 23603750 DOI: 10.1016/j.cellsig.2013.03.025  1
2013 Chowdhury S, Ongchin M, Sharratt E, Dominguez I, Wang J, Brattain MG, Rajput A. Intra-tumoral heterogeneity in metastatic potential and survival signaling between iso-clonal HCT116 and HCT116b human colon carcinoma cell lines. Plos One. 8: e60299. PMID 23560089 DOI: 10.1371/journal.pone.0060299  1
2012 Sabbah DA, Simms NA, Wang W, Dong Y, Ezell EL, Brattain MG, Vennerstrom JL, Zhong HA. N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα). Bioorganic & Medicinal Chemistry. 20: 7175-83. PMID 23121722 DOI: 10.1016/J.Bmc.2012.09.059  1
2012 Cheng Q, Ling X, Haller A, Nakahara T, Yamanaka K, Kita A, Koutoku H, Takeuchi M, Brattain MG, Li F. Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter. International Journal of Biochemistry and Molecular Biology. 3: 179-97. PMID 22773958  1
2012 Simms NA, Rajput A, Sharratt EA, Ongchin M, Teggart CA, Wang J, Brattain MG. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells. Bmc Cancer. 12: 221. PMID 22672900 DOI: 10.1186/1471-2407-12-221  1
2012 Sabbah DA, Simms NA, Brattain MG, Vennerstrom JL, Zhong H. Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases. Bioorganic & Medicinal Chemistry Letters. 22: 876-80. PMID 22212721 DOI: 10.1016/J.Bmcl.2011.12.044  1
2011 Sabbah DA, Brattain MG, Zhong H. Dual inhibitors of PI3K/mTOR or mTOR-selective inhibitors: Which way shall we go? Current Medicinal Chemistry. 18: 5528-5544. PMID 22172063  1
2011 Chowdhury S, Howell GM, Teggart CA, Chowdhury A, Person JJ, Bowers DM, Brattain MG. Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death. The Journal of Biological Chemistry. 286: 30937-48. PMID 21757750 DOI: 10.1074/Jbc.M110.212035  1
2011 Chowdhury S, Howell GM, Rajput A, Teggart CA, Brattain LE, Weber HR, Chowdhury A, Brattain MG. Identification of a novel TGFβ/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer. Plos One. 6: e19335. PMID 21559296 DOI: 10.1371/journal.pone.0019335  1
2010 Are C, Simms N, Rajput A, Rajupt A, Brattain M. The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cancer. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 12: 498-506. PMID 20815859 DOI: 10.1111/J.1477-2574.2010.00219.X  1
2009 Ongchin M, Sharratt E, Dominguez I, Simms N, Wang J, Cheney R, LeVea C, Brattain M, Rajput A. The effects of epidermal growth factor receptor activation and attenuation of the TGFbeta pathway in an orthotopic model of colon cancer. The Journal of Surgical Research. 156: 250-6. PMID 19524264 DOI: 10.1016/j.jss.2009.02.002  1
2009 Wang J, Rajput A, Kan JL, Rose R, Liu XQ, Kuropatwinski K, Hauser J, Beko A, Dominquez I, Sharratt EA, Brattain L, Levea C, Sun FL, Keane DM, Gibson NW, ... Brattain MG, et al. Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma. The Journal of Biological Chemistry. 284: 10912-22. PMID 19224914 DOI: 10.1074/Jbc.M809551200  1
2009 Sawhney RS, Liu W, Brattain MG. A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling. Journal of Cellular Physiology. 219: 152-61. PMID 19089993 DOI: 10.1002/jcp.21662  1
2008 Hu YP, Patil SB, Panasiewicz M, Li W, Hauser J, Humphrey LE, Brattain MG. Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor. Cancer Research. 68: 8004-13. PMID 18829558 DOI: 10.1158/0008-5472.Can-08-0280  1
2008 Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. Cancer Research. 68: 3152-60. PMID 18451140 DOI: 10.1158/0008-5472.Can-07-5348  1
2008 Zhao S, Ammanamanchi S, Brattain M, Cao L, Thangasamy A, Wang J, Freeman JW. Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells. The Journal of Biological Chemistry. 283: 11293-301. PMID 18310076 DOI: 10.1074/jbc.M800154200  1
2008 Spengler ML, Guo LW, Brattain MG. Phosphorylation mediates Sp1 coupled activities of proteolytic processing, desumoylation and degradation. Cell Cycle (Georgetown, Tex.). 7: 623-30. PMID 18239466 DOI: 10.4161/Cc.7.5.5402  1
2008 Rajput A, Dominguez San Martin I, Rose R, Beko A, Levea C, Sharratt E, Mazurchuk R, Hoffman RM, Brattain MG, Wang J. Characterization of HCT116 human colon cancer cells in an orthotopic model. The Journal of Surgical Research. 147: 276-81. PMID 17961596 DOI: 10.1016/J.Jss.2007.04.021  1
2007 Wang R, Brattain MG. The maximal size of protein to diffuse through the nuclear pore is larger than 60kDa. Febs Letters. 581: 3164-70. PMID 17588566 DOI: 10.1016/J.Febslet.2007.05.082  1
2007 Guo XN, Rajput A, Rose R, Hauser J, Beko A, Kuropatwinski K, LeVea C, Hoffman RM, Brattain MG, Wang J. Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model. Cancer Research. 67: 5851-8. PMID 17575153 DOI: 10.1158/0008-5472.Can-07-0049  1
2007 Wang J, Kuropatwinski K, Hauser J, Rossi MR, Zhou Y, Conway A, Kan JL, Gibson NW, Willson JK, Cowell JK, Brattain MG. Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis. Molecular Cancer Therapeutics. 6: 1143-50. PMID 17363507 DOI: 10.1158/1535-7163.Mct-06-0555  1
2007 Fakih MG, Trump DL, Muindi JR, Black JD, Bernardi RJ, Creaven PJ, Schwartz J, Brattain MG, Hutson A, French R, Johnson CS. A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1216-23. PMID 17317832 DOI: 10.1158/1078-0432.Ccr-06-1165  1
2007 Rajput A, Koterba AP, Kreisberg JI, Foster JM, Willson JK, Brattain MG. A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo. Cancer Research. 67: 665-73. PMID 17234777 DOI: 10.1158/0008-5472.Can-06-2773  1
2006 Javle MM, Yu J, Khoury T, Chadha KS, Chadha KC, Iyer RV, Foster J, Kuvshinoff BW, Gibbs JF, Geradts J, Black JD, Brattain MG. Akt expression may predict favorable prognosis in cholangiocarcinoma. Journal of Gastroenterology and Hepatology. 21: 1744-51. PMID 16984600 DOI: 10.1111/J.1440-1746.2006.04373.X  1
2006 Li F, Brattain MG. Role of the Survivin gene in pathophysiology. The American Journal of Pathology. 169: 1-11. PMID 16816356 DOI: 10.2353/Ajpath.2006.060121  1
2006 Chadha KS, Khoury T, Yu J, Black JD, Gibbs JF, Kuvshinoff BW, Tan D, Brattain MG, Javle MM. Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma. Annals of Surgical Oncology. 13: 933-9. PMID 16788754 DOI: 10.1245/Aso.2006.07.011  1
2006 Wang R, Brattain MG. AKT can be activated in the nucleus. Cellular Signalling. 18: 1722-31. PMID 16616456 DOI: 10.1016/J.Cellsig.2006.01.020  1
2006 Sawhney RS, Cookson MM, Omar Y, Hauser J, Brattain MG. Integrin alpha2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway. The Journal of Biological Chemistry. 281: 8497-510. PMID 16461767 DOI: 10.1074/Jbc.M600787200  1
2006 Spengler ML, Brattain MG. Sumoylation inhibits cleavage of Sp1 N-terminal negative regulatory domain and inhibits Sp1-dependent transcription. The Journal of Biological Chemistry. 281: 5567-74. PMID 16407261 DOI: 10.1074/Jbc.M600035200  1
2006 Zhou Y, Li S, Hu YP, Wang J, Hauser J, Conway AN, Vinci MA, Humphrey L, Zborowska E, Willson JK, Brattain MG. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis. Cancer Research. 66: 404-11. PMID 16397255 DOI: 10.1158/0008-5472.Can-05-2506  1
2005 Javle MM, Yu J, Chadha M, Khoury T, Levea CM, Gibbs JF, Iyer RV, Oleszek D, Brattain MG, Black JD. MAPK activation predicts poor survival after pancreatico-duodenectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 9578. PMID 27944052 DOI: 10.1200/Jco.2005.23.16_Suppl.9578  0.32
2005 Zhou Y, Brattain MG. Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis. Cancer Research. 65: 5848-56. PMID 15994962 DOI: 10.1158/0008-5472.Can-04-3509  1
2005 Hu YP, Venkateswarlu S, Sergina N, Howell G, St Clair P, Humphrey LE, Li W, Hauser J, Zborowska E, Willson JK, Brattain MG. Reorganization of ErbB family and cell survival signaling after Knock-down of ErbB2 in colon cancer cells. The Journal of Biological Chemistry. 280: 27383-92. PMID 15888451 DOI: 10.1074/Jbc.M414238200  1
2005 Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, Freeman JW. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. The Journal of Biological Chemistry. 280: 10047-54. PMID 15647279 DOI: 10.1074/Jbc.M408680200  0.36
2005 Li F, Ling X, Huang H, Brattain L, Apontes P, Wu J, Binderup L, Brattain MG. Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines. Oncogene. 24: 1385-95. PMID 15608672 DOI: 10.1038/Sj.Onc.1208330  1
2005 Spengler ML, Kennett SB, Moorefield KS, Simmons SO, Brattain MG, Horowitz JM. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism. Cellular Signalling. 17: 153-66. PMID 15494207 DOI: 10.1016/J.Cellsig.2004.06.007  1
2004 Sawhney RS, Cookson MM, Sharma B, Hauser J, Brattain MG. Autocrine transforming growth factor alpha regulates cell adhesion by multiple signaling via specific phosphorylation sites of p70S6 kinase in colon cancer cells. The Journal of Biological Chemistry. 279: 47379-90. PMID 15304500 DOI: 10.1074/Jbc.M402031200  1
2004 Wang J, Sergina N, Ko TC, Gong J, Brattain MG. Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity. The Journal of Biological Chemistry. 279: 40237-44. PMID 15271980 DOI: 10.1074/Jbc.M401665200  1
2004 Ammanamanchi S, Brattain MG. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. The Journal of Biological Chemistry. 279: 32620-5. PMID 15155736 DOI: 10.1074/Jbc.M402691200  1
2004 Wilkinson NW, Black JD, Roukhadze E, Driscoll D, Smiley S, Hoshi H, Geradts J, Javle M, Brattain M. Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 8: 448-53. PMID 15120370 DOI: 10.1016/J.Gassur.2004.01.006  1
2004 Jackson JG, St Clair P, Sliwkowski MX, Brattain MG. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects. Cancer Research. 64: 2601-9. PMID 15059917 DOI: 10.1158/0008-5472.Can-03-3106  1
2004 Ammanamanchi S, Tillekeratne MP, Ko TC, Brattain MG. Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells. Cancer Research. 64: 2509-15. PMID 15059906 DOI: 10.1158/0008-5472.Can-03-2654  1
2004 Ling X, Bernacki RJ, Brattain MG, Li F. Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest. The Journal of Biological Chemistry. 279: 15196-203. PMID 14722122 DOI: 10.1074/Jbc.M310947200  1
2003 Black JD, Brattain MG, Krishnamurthi SA, Dawson DM, Willson JK. ErbB family targeting. Current Opinion in Investigational Drugs (London, England : 2000). 4: 1451-4. PMID 14763131  1
2003 DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW. Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines. Oncogene. 22: 7781-95. PMID 14586404 DOI: 10.1038/Sj.Onc.1206966  1
2003 Awwad RA, Sergina N, Yang H, Ziober B, Willson JK, Zborowska E, Humphrey LE, Fan R, Ko TC, Brattain MG, Howell GM. The role of transforming growth factor alpha in determining growth factor independence. Cancer Research. 63: 4731-8. PMID 12907656  1
2003 Malik SN, Siu LL, Rowinsky EK, deGraffenried L, Hammond LA, Rizzo J, Bacus S, Brattain MG, Kreisberg JI, Hidalgo M. Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 2478-86. PMID 12855621  1
2003 Ammanamanchi S, Freeman JW, Brattain MG. Acetylated sp3 is a transcriptional activator. The Journal of Biological Chemistry. 278: 35775-80. PMID 12837748 DOI: 10.1074/Jbc.M305961200  1
2003 Gong J, Ammanamanchi S, Ko TC, Brattain MG. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Cancer Research. 63: 3340-6. PMID 12810668  1
2003 Malik SN, Bedolla RG, Hidalgo M, Brattain MG, Kreisberg JI. Immunohistochemical determination of EGFR-tyrosine kinase inhibition in clinical samples. Methods in Molecular Medicine. 85: 135-40. PMID 12710204 DOI: 10.1385/1-59259-380-1:135  1
2003 Sawhney RS, Sharma B, Humphrey LE, Brattain MG. Integrin alpha2 and extracellular signal-regulated kinase are functionally linked in highly malignant autocrine transforming growth factor-alpha-driven colon cancer cells. The Journal of Biological Chemistry. 278: 19861-9. PMID 12657625 DOI: 10.1074/Jbc.M213162200  1
2003 Traicoff JL, Periyasamy S, Brattain MG, Grady W, Casey G. Reconstitution of TGF-beta sensitivity in the VACO-411 human colon carcinoma line by somatic cell fusion with MCF-7. Journal of Biomedical Science. 10: 253-9. PMID 12595761 DOI: 10.1007/Bf02256060  1
2002 Bandyopadhyay A, Zhu Y, Malik SN, Kreisberg J, Brattain MG, Sprague EA, Luo J, López-Casillas F, Sun LZ. Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells. Oncogene. 21: 3541-51. PMID 12032856 DOI: 10.1038/Sj.Onc.1205439  1
2002 Wang D, Patil S, Li W, Humphrey LE, Brattain MG, Howell GM. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells. Oncogene. 21: 2785-96. PMID 11973637 DOI: 10.1038/Sj.Onc.1205375  1
2002 Venkateswarlu S, Dawson DM, St Clair P, Gupta A, Willson JK, Brattain MG. Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells. Oncogene. 21: 78-86. PMID 11791178 DOI: 10.1038/Sj.Onc.1205011  1
2002 Sawhney RS, Zhou GH, Humphrey LE, Ghosh P, Kreisberg JI, Brattain MG. Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands. The Journal of Biological Chemistry. 277: 75-86. PMID 11684674 DOI: 10.1074/Jbc.M103268200  1
2001 Venkatasubbarao K, Ammanamanchi S, Brattain MG, Mimari D, Freeman JW. Reversion of transcriptional repression of Sp1 by 5 aza-2′ deoxycytidine restores TGF-β type II receptor expression in the pancreatic cancer cell line MIA PaCa-2 Cancer Research. 61: 6239-6247. PMID 11507078  1
2001 Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG. Autocrine TGFβ signaling mediates vitamin D3 analog-induced growth inhibition in breast cells Journal of Cellular Physiology. 188: 383-393. PMID 11473365 DOI: 10.1002/Jcp.1125  1
2001 Ammanamanchi S, Brattain MG. 5-AzaC Treatment Enhances Expression of Transforming Growth Factor-β Receptors through Down-regulation of Sp3 Journal of Biological Chemistry. 276: 32854-32859. PMID 11443124 DOI: 10.1074/Jbc.M103951200  1
2001 Ammanamanchi S, Brattain MG. Sp3 Is a Transcriptional Repressor of Transforming Growth Factor-β Receptors Journal of Biological Chemistry. 276: 3348-3352. PMID 11027677 DOI: 10.1074/Jbc.M002462200  1
2000 Periyasamy S, Ammanamanchi S, Tillekeratne MPM, Brattain MG. Repression of transforming growth factor-β receptor type I promoter expression by Sp1 deficiency Oncogene. 19: 4660-4667. PMID 11030155 DOI: 10.1038/Sj.Onc.1203822  1
2000 Jackson JG, Kreisberg JI, Koterba AP, Yee D, Brattain MG. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells. Oncogene. 19: 4574-81. PMID 11030146 DOI: 10.1038/Sj.Onc.1203825  1
2000 Yang H, Jiang D, Li W, Liang J, Gentry LE, Brattain MG. Defective cleavage of membrane bound TGFα leads to enhanced activation of the EGF receptor in malignant cells Oncogene. 19: 1901-1914. PMID 10773880 DOI: 10.1038/Sj.Onc.1203513  1
2000 Liu Y, Zhong X, Li W, Brattain MG, Banerji SS. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells. The Journal of Biological Chemistry. 275: 12231-6. PMID 10766860 DOI: 10.1074/Jbc.275.16.12231  1
1999 Awwad R, Humphrey LE, Periyasamy B, Scovell W, Li W, Coleman K, Lynch M, Carboni J, Brattain MG, Howell GM. The EGF/TGFalpha response element within the TGFalpha promoter consists of a multi-complex regulatory element. Oncogene. 18: 5923-35. PMID 10557079 DOI: 10.1038/Sj.Onc.1202982  1
1999 Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JKV. Contextual effects of transforming growth factor β on the tumorigenicity of human colon carcinoma cells Cancer Research. 59: 4725-4731. PMID 10493532  1
1999 Wang D, Sun L, Zborowska E, Willson JKV, Gong J, Verraraghavan J, Brattain MG. Control of type II transforming growth factor-β receptor expression by integrin ligation Journal of Biological Chemistry. 274: 12840-12847. PMID 10212271 DOI: 10.1074/Jbc.274.18.12840  1
1998 Jiang D, Yang H, Willson JKV, Liang J, Humphrey LE, Zborowska E, Wang D, Foster J, Fan R, Brattain MG. Autocrine transforming growth factor provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states Journal of Biological Chemistry. 273: 31471-31479. PMID 9813060 DOI: 10.1074/Jbc.273.47.31471  1
1998 Wang D, Li W, Jiang W, Humphrey LE, Howell GM, Brattain MG. Autocrine TGFα expression in the regulation of initiation of human colon carcinoma growth Journal of Cellular Physiology. 177: 387-395. PMID 9808147 DOI: 10.1002/(Sici)1097-4652(199812)177:3<387::Aid-Jcp2>3.0.Co;2-L  1
1998 Ko Y, Banerji SS, Liu Y, Li W, Liang J, Soule HD, Pauley RJ, Willson JK, Zborowska E, Brattain MG. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells. Journal of Cellular Physiology. 176: 424-34. PMID 9648930 DOI: 10.1002/(Sici)1097-4652(199808)176:2<424::Aid-Jcp21>3.0.Co;2-1  1
1998 Ammanamanchi S, Kim SJ, Sun LZ, Brattain MG. Induction of transforming growth factor-β receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine Journal of Biological Chemistry. 273: 16527-16534. PMID 9632722 DOI: 10.1074/Jbc.273.26.16527  1
1998 Howell GM, Humphrey LE, Awwad RA, Wang D, Koterba A, Periyasamy B, Yang J, Li W, Willson JK, Ziober BL, Coleman K, Carboni J, Lynch M, Brattain MG. Aberrant regulation of transforming growth factor-alpha during the establishment of growth arrest and quiescence of growth factor independent cells. The Journal of Biological Chemistry. 273: 9214-23. PMID 9535913 DOI: 10.1074/Jbc.273.15.9214  0.56
1998 Jiang D, Liang J, Humphrey LE, Yang H, Brattain MG. Expression of TGFα autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor Journal of Cellular Physiology. 175: 174-183. PMID 9525476 DOI: 10.1002/(SICI)1097-4652(199805)175:2<174::AID-JCP7>3.0.CO;2-L  1
1998 Wu G, Fan RS, Li W, Srinivas V, Brattain MG. Regulation of transforming growth factor-β type II receptor expression in human breast cancer MCF-7 cells by vitamin D3 and its analogues Journal of Biological Chemistry. 273: 7749-7756. PMID 9516484 DOI: 10.1074/Jbc.273.13.7749  1
1998 Ko Y, Koli KM, Banerji SS, Li W, Zborowska E, Willson JK, Brattain MG, Arteaga CL. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells. International Journal of Oncology. 12: 87-94. PMID 9454891  1
1998 Gong J, Ko TC, Brattain MG. Disruption of fibronectin binding to the α5β1 integrin stimulates the expression of cyclin-dependent kinases and DNA synthesis through activation of extracellular signal-regulated kinase Journal of Biological Chemistry. 273: 1662-1669. PMID 9430710 DOI: 10.1074/jbc.273.3.1662  1
1998 Howell GM, Humphrey LE, Ziober BL, Awwad R, Periyasamy B, Koterba A, Li W, Willson JK, Coleman K, Carboni J, Lynch M, Brattain MG. Regulation of transforming growth factor alpha expression in a growth factor-independent cell line. Molecular and Cellular Biology. 18: 303-13. PMID 9418877  1
1997 Jiang W, Tillekeratne MP, Brattain MG, Banerji SS. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells. Biochemistry. 36: 14786-93. PMID 9402753 DOI: 10.1021/Bi9717892  1
1997 Wu G, Fan RS, Li W, Ko TC, Brattain MG. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells Oncogene. 15: 1555-1563. PMID 9380407 DOI: 10.1038/Sj.Onc.1201329  1
1997 Koli KM, Ramsey TT, Ko Y, Dugger TC, Brattain MG, Arteaga CL. Blockade of transforming growth factor-β signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells Journal of Biological Chemistry. 272: 8296-8302. PMID 9079651 DOI: 10.1074/jbc.272.13.8296  1
1997 Liu Z, Brattain MG, Appert H. Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7 Biochemical and Biophysical Research Communications. 231: 283-289. PMID 9070264 DOI: 10.1006/bbrc.1997.6083  1
1997 Gong J, Wang D, Sun L, Zborowska E, Willson JKV, Brattain MG. Role of α5β1 integrin in determining malignant properties of colon carcinoma cells Cell Growth and Differentiation. 8: 83-90. PMID 8993837  1
1996 Dobre C, Humphrey L, Brattain M. Autocrine transforming growth factor-beta (TGF beta) modulates the 120 kD and 105 kD retinoblastoma (RB) protein species in CBS colon carcinoma cells as revealed by an anti-sense TGF beta 1 expression vector. International Journal of Oncology. 8: 469-75. PMID 21544384 DOI: 10.3892/Ijo.8.3.469  0.44
1996 Brattain MG, Ko Y, Banerji SS, Wu G, Willson JK. Defects of TGF-beta receptor signaling in mammary cell tumorigenesis. Journal of Mammary Gland Biology and Neoplasia. 1: 365-72. PMID 10887510  1
1996 Brattain MG, Markowitz SD, Willson JKV. The type II transforming growth factor-β receptor as a tumor-suppressor gene Current Opinion in Oncology. 8: 49-53. PMID 8868100 DOI: 10.1097/00001622-199601000-00009  1
1996 Periyasamy S, Sun L, Gentry LE, Brattain MG. Differential control of expression of type I and type II receptors of transforming growth factor-β in colon carcinoma cells Journal of Cellular Physiology. 168: 711-720. PMID 8816926 DOI: 10.1002/(Sici)1097-4652(199609)168:3<711::Aid-Jcp24>3.0.Co;2-#  1
1996 Wang J, Han W, Zborowska E, Liang J, Wang X, Willson JKV, Sun L, Brattain MG. Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells Journal of Biological Chemistry. 271: 17366-17371. PMID 8663343 DOI: 10.1074/Jbc.271.29.17366  1
1996 Brattain MG. Autocrine transforming growth factor-α is associated with modulation of a 130 kD RB protein species and 116/110 Rb as revealed by an antisense TGFα expression vector International Journal of Oncology. 8: 1025-1033.  1
1996 Dobre CV, Humphrey LE, Brattain MG. Autocrine Transforming Growth Factor-β (TGFβ) modulates the 120 kD and 105 kD Retinoblastoma (RB) protein species in CBS colon carcinoma cells as revealed by an anti-sense TGFβ1 expression vector International Journal of Oncology. 8: 469-475.  1
1995 Howell GM, Ziober BL, Humphrey LE, Willson JKV, Sun L, Lynch M, Brattain MG. Regulation of autocrine gastrin expression by the TGFα autocrine loop Journal of Cellular Physiology. 162: 256-265. PMID 7822434 DOI: 10.1002/Jcp.1041620211  1
1995 Sechrist GL, Mulder KM, Zhou GHK, Periyasamy S, Brattain MG. Transforming Growth Factor β Isoform-specific Differences in Interactions with Type I and II Transforming Growth Factor β Receptors Cancer Research. 55: 2056-2062. PMID 7743502  1
1995 Wang D, Birkenmeier TM, Yang J, Venkateswarlu S, Humphrey L, Brattain MG, Sun L. Release from quiescence stimulates the expression of integrin α5β1 which regulates DNA synthesis in human fibrosarcoma HT1080 cells Journal of Cellular Physiology. 164: 499-508. PMID 7650060 DOI: 10.1002/Jcp.1041640308  1
1995 Zhou GHK, Sechrist GL, Brattain MG, Mulder KM. Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGFβ isoforms Journal of Cellular Physiology. 165: 512-520. PMID 7593230 DOI: 10.1002/Jcp.1041650309  1
1995 Wang D, Zhou GH, Birkenmeier TM, Gong J, Sun L, Brattain MG. Autocrine transforming growth factor β1 modulates the expression of integrin α5β1 in human colon carcinoma FET cells Journal of Biological Chemistry. 270: 14154-14159. PMID 7539800 DOI: 10.1074/Jbc.270.23.14154  1
1994 Brattain MG, Howell G, Sun LuZhe, Willson JKV. Growth factor balance and tumor progression Current Opinion in Oncology. 6: 77-81. PMID 8204695  1
1994 Sun L, Shaoping WU, Coleman K, Fields KC, Humphrey LE, Brattain MG. Autocrine transforming growth factor-β1 and β2 expression is increased by cell crowding and quiescence in colon carcinoma cells Experimental Cell Research. 214: 215-224. PMID 8082724 DOI: 10.1006/Excr.1994.1251  1
1994 Sun L, Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang XF, Brattain MG. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells Journal of Biological Chemistry. 269: 26449-26455. PMID 7929366  1
1993 Wu SP, Sun LZ, Willson JK, Humphrey L, Kerbel R, Brattain MG. Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties Cell Growth &Amp; Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 4: 115-123. PMID 8494782  1
1993 Ziober BL, Willson JKV, Hymphrey LE, Childress-Fields K, Brattain MG. Autocrine transforming growth factor-α is associated with progression of transformed properties in human colon cancer cells Journal of Biological Chemistry. 268: 691-698. PMID 8416972  1
1993 Lynch MJ, Pelosi L, Carboni JM, Merwin J, Coleman K, Wang RC, Lin PF, Henry DL, Brattain MG. Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET. Cancer Research. 53: 4041-7. PMID 8358733  0.36
1993 Howell GM, Sun L, Ziober BL, Wu SP, Brattain MG. The role of growth regulatory aberrations in progression of human colon carcinoma Cancer and Metastasis Reviews. 12: 275-286. PMID 8281613 DOI: 10.1007/Bf00665958  1
1993 Brattain MG, Mulder KM, Wu SP, Howell G, Sun L, Willson JKV, Ziober BL. Altered Expression of Transforming Growth Factor-α and Transforming Growth Factor-β Autocrine Loops in Cancer Cells Advances in Molecular and Cell Biology. 7: 35-59. DOI: 10.1016/S1569-2558(08)60234-9  1
1992 Wu S, Theodorescu D, Kerbel RS, Willson JKV, Mulder KM, Humphrey LE, Brattain MG. TGF-βi is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector Journal of Cell Biology. 116: 187-196. PMID 1730743 DOI: 10.1083/Jcb.116.1.187  1
1991 Gross ME, Garcia R, Boman BM, Yeoman LC, Zorbas MA, Gallick GE, Danels VJ, Olive M, Brattain MG. Cellular Growth Response to Epidermal Growth Factor in Colon Carcinoma Cells with an Amplified Epidermal Growth Factor Receptor Derived from a Familial Adenomatous Polyposis Patient Cancer Research. 51: 1452-1459. PMID 1847663  1
1991 Saeki T, Cristiano A, Lynch MJ, Brattain M, Kim N, Normanno N, Kenney N, Ciardiello F, Salomon DS. Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene Molecular Endocrinology. 5: 1955-1963. PMID 1791840 DOI: 10.1210/Mend-5-12-1955  1
1991 Long BH, Wang L, Lorico A, Wang RC, Brattain MG, Casazza AM. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines. Cancer Research. 51: 5275-83. PMID 1717144  0.32
1990 Hoosein NM, Kiener PA, Curry RC, Brattain MG. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide Experimental Cell Research. 186: 15-21. PMID 2298233 DOI: 10.1016/0014-4827(90)90204-N  1
1990 Mulder KM, Humphrey LE, Choi HG, Childress-Fields KE, Brattain MG. Evidence for c-myc in the signaling pathway for TGF-β in well-differentiated human colon carcinoma cells Journal of Cellular Physiology. 145: 501-507. PMID 2273056 DOI: 10.1002/Jcp.1041450316  1
1990 Mulder KM, Zhong Q, Choi HG, Humphrey LE, Brattain MG. Inhibitory Effects of Transforming Growth Factor β x on Mitogenic Response, Transforming Growth Factor a, and c-myc in Quiescent, Well-Differentiated Colon Carcinoma Cells Cancer Research. 50: 7581-7586. PMID 1701348  1
1989 Levine AE, Black B, Brattain MG. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-β binding to a human colon carcinoma cell line Journal of Cellular Physiology. 138: 459-466. PMID 2925796 DOI: 10.1002/Jcp.1041380304  1
1989 Mulder KM, Brattain MG. Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells Molecular Endocrinology. 3: 1215-1222. PMID 2674694 DOI: 10.1210/Mend-3-8-1215  1
1989 Mulder KM, Brattain MG. Continous maintenance of transformed fibroblasts under reduced serum conditions: Utility as a model system for investigating growth factor-specific effects in nonquiescent cells Journal of Cellular Physiology. 138: 450-458. PMID 2647770 DOI: 10.1002/Jcp.1041380303  1
1989 Hoosein NM, Black BE, Brattain DE, Brattain MG. Promotion of differentiation in human colon carcinoma cells by vasoactive intestinal polypeptide. Regulatory Peptides. 24: 15-26. PMID 2544928 DOI: 10.1016/0167-0115(89)90207-3  1
1989 Hoosein NM, Thim L, Jørgensen KH, Brattain MG. Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells Febs Letters. 247: 303-306. PMID 2541019 DOI: 10.1016/0014-5793(89)81357-2  1
1989 Chakrabarty S, Jan Y, Brattain MG, Tobon A, Varani J. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta. Cancer Research. 49: 2112-7. PMID 2539253  1
1989 Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress KE, Brattain DE, Brattain MG. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-β1 Experimental Cell Research. 181: 442-453. PMID 2538337 DOI: 10.1016/0014-4827(89)90101-8  1
1988 Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A. Epithelial Polarity, Villin Expression, and Enterocytic Differentiation of Cultured Human Colon Carcinoma Cells: A Survey of Twenty Cell Lines Cancer Research. 48: 1936-1942. PMID 3349466  1
1988 Chakrabarty S, Tobon A, Varani J, Brattain MG. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta. Cancer Research. 48: 4059-64. PMID 3289738  1
1988 Boyd DD, Levine AE, Brattain DE, McKnight MK, Brattain MG. Comparison of Growth Requirements of Two Human Intratumoral Colon Carcinoma Cell Lines in Monolayer and Soft Agarose Cancer Research. 48: 2469-2474. PMID 3281751  1
1988 Wan CW, McKnight MK, Brattain DE, Brattain MG, Yeoman LC. Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines Cancer Letters. 43: 139-143. PMID 3264518 DOI: 10.1016/0304-3835(88)90226-1  1
1988 Watkins LF, Brattain MG, Levine AE. Modulation of a high molecular weight form of transforming growth factor-α in human colon carcinoma cell lines Cancer Letters. 40: 59-70. PMID 3259465 DOI: 10.1016/0304-3835(88)90262-5  1
1988 Hoosein NM, Kiener PA, Curry RC, Rovati LC, McGilbra DK, Brattain MG. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines Cancer Research. 48: 7179-7183. PMID 3191491  1
1988 Mulder KM, Ramey MK, Hoosein NM, Levine AE, Hinshaw XH, Brattain DE, Brattain MG. Characterization of transforming growth factor-β-resistant subclones isolated from a transforming growth factor-β-sensitive human colon carcinoma cell line Cancer Research. 48: 7120-7125. PMID 3191488  1
1988 Mulder KM, Brattain MG. Alterations in c-myc expression in relation to maturational status of human colon carcinoma cells International Journal of Cancer. 42: 64-70. PMID 3164710 DOI: 10.1002/Ijc.2910420113  1
1988 Boyd D, Florent G, Childress-Fields K, Brattain MG. Alteration in the behavior of a colon carcinoma cell line by extracellular matrix components Cancer Letters. 41: 81-90. PMID 3164644 DOI: 10.1016/0304-3835(88)90058-4  1
1988 Hoosein NM, Brattain DE, McKnight MK, Childress KE, Chakrabarty S, Brattain MG. Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line. Cancer Letters. 40: 219-32. PMID 3164250 DOI: 10.1016/0304-3835(88)90014-6  1
1988 Boyd D, Florent G, Chakrabarty S, Brattain D, Brattain MG. Alterations of the biological characteristics of a colon carcinoma cell line by colon-derived substrata material. Cancer Research. 48: 2825-31. PMID 3162826  1
1988 Hoosein NM, Brattain DE, McKnight MK, Brattain MG. Comparison of the effects of transforming growth factor β, N,N-dimethylformamide, and retinoic acid on transformed and nontransformed fibroblasts Experimental Cell Research. 175: 125-135. PMID 3162213 DOI: 10.1016/0014-4827(88)90260-1  1
1988 Mulder KM, Levine AE, Hernandez X, McKnight MK, Brattain DE, Brattain MG. Modulation of C-myc by transforming growth factor-β in human colon carcinoma cells Biochemical and Biophysical Research Communications. 150: 711-716. PMID 2893611 DOI: 10.1016/0006-291X(88)90449-4  1
1987 Boyd D, Bialoski S, Brattain MG. The specific binding of transferrin to the murine fibroblast cell lines AKR-2B and its malignant counterpart AKR-MCA may be related to the transformed state Cancer Letters. 36: 263-271. PMID 3652028 DOI: 10.1016/0304-3835(87)90019-X  1
1987 Hoosein NM, Brattain DE, McKnight MK, Levine AE, Brattain MG. Characterization of the Inhibitory Effects of Transforming Growth Factor-β on a Human Colon Carcinoma Cell Line Cancer Research. 47: 2950-2954. PMID 3471320  1
1987 Chakrabarty S, Brattain MG, Ochs RL, Varani J. Modulation of fibronectin, laminin, and cellular adhesion in the transformation and differentiation of murine AKR fibroblasts. Journal of Cellular Physiology. 133: 415-25. PMID 3320063 DOI: 10.1002/Jcp.1041330302  1
1987 Chakrabarty S, Brattain MG. Molecular comparisons of acquired and native mitomycin C resistance in human colon carcinoma cells. Cancer Letters. 37: 267-76. PMID 3119191 DOI: 10.1016/0304-3835(87)90111-X  1
1987 Levine AE, Crandall CA, Brattain MG. Regulation of growth inhibitory activity in transformed mouse embryo fibroblasts Experimental Cell Research. 171: 357-366. PMID 2887448 DOI: 10.1016/0014-4827(87)90168-6  1
1986 Chakrabarty S, Miller CA, Brattain MG. Selective modifications of cellular proteins in intratumoral subpopulations of human colonic carcinoma cells. Cancer Investigation. 4: 5-14. PMID 3955419 DOI: 10.3109/07357908609039822  1
1986 Marks ME, Ziober BL, Brattain MG. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells. Cancer Research. 46: 5248-58. PMID 3756877  1
1986 Chakrabarty S, Danels YJ, Long BH, Willson JK, Brattain MG. Circumvention of deficient activation in mitomycin C-resistant human colonic carcinoma cells by the mitomycin C analogue BMY25282. Cancer Research. 46: 3456-8. PMID 3754788  1
1986 Levine AE, Crandall CA, Brattain D, Chakrabarty S, Brattain MG. Retinoic acid restores normal growth control to a transformed mouse embryo fibroblast cell line. Cancer Letters. 33: 33-43. PMID 3490304 DOI: 10.1016/0304-3835(86)90099-6  1
1986 Chakrabarty S, Brattain MG. Transforming growth factors from human colonic carcinoma cells induced molecular alterations in untransformed mouse AKR embryo fibroblasts. Cell Biology International Reports. 10: 891-5. PMID 3466722 DOI: 10.1016/0309-1651(86)90107-4  1
1986 Brattain MG, Willson JK, Long BH, Chakrabarty S, Yeoman LC, Stringfellow DA. Overcoming mitomycin C resistance with semisynthetic derivatives. Progress in Clinical and Biological Research. 223: 63-79. PMID 3101070  1
1985 Chakrabarty S, Jan Y, Miller CA, Brattain MG. Selective nuclear protein phosphorylation/dephosphorylation in subpopulations of human colonic carcinoma cells. Cancer Letters. 28: 291-7. PMID 4052998 DOI: 10.1016/0304-3835(85)90037-0  1
1985 Chakrabarty S, Jan Y, Miller CA, Brattain MG. Selective protein phosphorylation in heterogeneous subpopulations of human colon carcinoma cells. Cancer Research. 45: 743-50. PMID 3967245  1
1985 Willson JK, Long BH, Chakrabarty S, Brattain DE, Brattain MG. Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells. Cancer Research. 45: 5281-6. PMID 3931904  1
1985 Taylor CW, Brattain MG, Yeoman LC. Occurrence of Cytosolic Protein and Phosphoprotein Changes in Human Colon Tumor Cells with the Development of Resistance to Mitomycin C Cancer Research. 45: 4422-4427. PMID 3928156  1
1985 Chakrabarty S, Jan Y, Son J, Miller CA, Brattain MG. Selective phosphorylation of cytosol proteins associated with transformation and restoration of normal phenotype in AKR mouse embryo fibroblasts. Cancer Research. 45: 2170-6. PMID 3872713  1
1985 Chakrabarty S, Brattain MG. Modulation of cellular phosphoprotein profiles in transformation and redifferentiation of murine AKR embryonic fibroblastic cells. Cancer Letters. 29: 151-5. PMID 3865700 DOI: 10.1016/0304-3835(85)90153-3  1
1985 Levine AE, McRae LJ, Hamilton DA, Brattain DE, Yeoman LC, Brattain MG. Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line. Cancer Research. 45: 2248-54. PMID 3857117  1
1985 Marks ME, Ziober BL, Brattain MG. Cell surface features associated with differentiation-induction of methylcholanthrene-transformed AKR-2B fibroblasts by N,N-dimethylformamide. Cancer Research. 45: 1276-84. PMID 3855694  1
1985 Long BH, Musial ST, Brattain MG. Single- and Double-Strand DNA Breakage and Repair in Human Lung Adenocarcinoma Cells Exposed to Etoposide and Teniposide Cancer Research. 45: 3106-3112. PMID 3839166  1
1985 Levine AE, McRae LJ, Brattain MG. Changes in Receptor Occupancy and Growth Factor Responsiveness Induced by Treatment of a Transformed Mouse Embryo Cell Line with N,N-Dimethylformamide Cancer Research. 45: 6401-6405. PMID 2998599  1
1985 Levine AE, Hamilton DA, McRae LJ, Brattain MG. Elevated growth factor levels in transformed mouse embryo cells treated with N,N-dimethylformamide. Cancer Research. 45: 108-11. PMID 2981156  1
1985 Brattain MG, Brattain DE, Willson JKV. Heterogeneity of human colon carcinoma Federation Proceedings. 44.  1
1985 Chakrabarty S, Jan Y, Brattain MG. Molecular alterations as a function of transformation and differentiation in murine fibroblastic cells Federation Proceedings. 44.  1
1985 Miller C, Jan Y, Brattain MG, Chakrabarty S. Molecular heterogeneity in subpopulations of human colonic carcinoma cells Federation Proceedings. 44.  1
1985 Musial ST, Brattain MG, Long BH. Reversed sensitivity to anticancer drugs VP16-213 (etoposide) and mitomycin C by human lung carcinoma cell line Federation Proceedings. 44.  1
1985 Levine AE, Yeoman LC, Brattain MG. Tumor inhibitory factor acts as a differentiation agent Federation Proceedings. 44.  1
1985 Crandall CA, Small S, Levine AE, Brattain MG. Modulation of growth factor levels by differentiation agents Federation Proceedings. 44.  1
1985 Moosic JP, Taylor CW, Brattain MG, Yeoman LC. Analysis of high molecular weight human colon tumor antigens using monoclonal antibodies Proceedings of the American Association For Cancer Research. 1259.  1
1985 Moosic JP, Taylor CW, Brattain MG, Yeoman LC. Partial characterization of high molecular weight human colon tumor antigens using monoclonal antibodies Federation Proceedings. 44.  1
1984 Long BH, Musial ST, Brattain MG. Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: A quantitative structure-activity relationship Biochemistry. 23: 1183-1188. PMID 6712942 DOI: 10.1021/Bi00301A024  1
1984 Levine AE, Hamilton DA, Yeoman LC, Busch H, Brattain MG. Identification of a tumor inhibitory factor in rat ascites fluid. Biochemical and Biophysical Research Communications. 119: 76-82. PMID 6704134 DOI: 10.1016/0006-291X(84)91620-6  1
1984 Chakrabarty S, McRae LJ, Levine AE, Brattain MG. Restoration of normal growth control and membrane antigen composition in malignant cells by N,N-dimethylformamide. Cancer Research. 44: 2181-5. PMID 6608991  1
1984 Marks ME, Brattain MG. Induction of plasma membrane alterations in AKR-2B mouse embryo fibroblasts by endogenous growth factors from malignant human cells. International Journal of Cancer. Journal International Du Cancer. 33: 139-46. PMID 6582050 DOI: 10.1002/Ijc.2910330121  1
1984 Willson JK, Long BH, Marks ME, Brattain DE, Wiley JE, Brattain MG. Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations. Cancer Research. 44: 5880-5. PMID 6437674  1
1984 Brattain MG, Levine AE, Chakrabarty S, Yeoman LC, Willson JK, Long B. Heterogeneity of human colon carcinoma. Cancer Metastasis Reviews. 3: 177-91. PMID 6437669 DOI: 10.1007/Bf00048384  1
1984 Long BH, Wiiison JKV, Brattain DE, Muslal S, Brattain MG. Effects of mitomycin on human colon carcinoma cells Journal of the National Cancer Institute. 73: 787-792. PMID 6434780 DOI: 10.1093/jnci/73.4.787  1
1984 Taylor CW, Brattain MG, Yeoman LC. Rate of Growth and Extent off Differentiation Reflected by Cytoplasmic Proteins and Antigens of Human Colon Tumor Cell Lines Cancer Research. 44: 1200-1205. PMID 6362859  1
1984 Miller C, Brattain D, Brattain MG, Chakrabarty S. Alterations in membrane protein glycosylation of human colonic carcinoma cells in conjunction with the development of a mitomycin C resistant phenotype Federation Proceedings. 43.  1
1984 Jan Y, Miller C, Brattain MG, Chakrabarty S. Variations on cell surface carbohydrate expression in subpopulations of human colonic carcinoma cells Federation Proceedings. 43.  1
1984 Brattain MG, McRae LJ, Chakrabarty S, Levine AE. Restoration of normal growth control to a transformed mouse fibroblast cell line induced by differentiation agents Federation Proceedings. 43.  1
1984 McRae LJ, Hamilton DA, Levine AE, Brattain MG. Identification of a tumor inhibitory factor from rat and human sources Federation Proceedings. 43.  1
1983 Brattain MG, Marks ME, McCombs J, Finely W, Brattain DE. Characterization of human colon carcinoma cell lines isolated from a single primary tumour. British Journal of Cancer. 47: 373-81. PMID 6830688 DOI: 10.1038/Bjc.1983.56  1
1983 Marks ME, Danbury BH, Miller CA, Brattain MG. Cell surface proteins and glycoproteins from biologically different human colon carcinoma cell lines. Journal of the National Cancer Institute. 71: 663-71. PMID 6578361 DOI: 10.1093/Jnci/71.4.663  1
1983 Chan PK, Frakes R, Brattain MG, Smetana K, Busch H, Tan EM. Indirect immunofluorescence studies of proliferating cell nuclear antigen in nucleoli of human tumor and normal tissues Cancer Research. 43: 3770-3777. PMID 6134581  1
1983 Long BH, Musial ST, Schaub DS, Brattain MG. In vivo DNA breakage produced by structural congeners of VP-16-213 (etoposide) and VM-26 (Teniposide) Federation Proceedings. 42.  1
1982 Brattain MG, Brattain DE, Sarrif AM, McRae LJ, Fine WD, Hawkins JG. Enhancement of growth of human colon tumor cell lines by feeder layers of murine fibroblasts Journal of the National Cancer Institute. 69: 767-771. PMID 6956756 DOI: 10.1093/Jnci/69.4.767  1
1981 Brattain MG, Brattain DE, Fine WD, Khaled FM, Marks ME, Kimball PM, Arcolano LA, Danbury BH. Initiation and characterization of cultures of human colonic carcinoma with different biological characteristics utilizing feeder layers of confluent fibroblasts. Oncodevelopmental Biology and Medicine : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 2: 355-66. PMID 7329817  1
1981 Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE. Heterogeneity of Malignant Cells from a Human Colonic Carcinoma Cancer Research. 41: 1751-1756. PMID 7214343  1
1981 Kimball PM, Brattain MG, White WE. Characterization of an unusual isoenzyme of N-acetyl-beta-D-hexosaminidase from a human colonic carcinoma cell line. The Biochemical Journal. 193: 109-13. PMID 6458273  1
1980 Strobel Stevens J, Fine D, Webb M, Sarrif AM, Brattain MG. Establishment of Mouse Colonic Carcinoma Cell Lines with Different Metastatic Properties Cancer Research. 40: 2142-2146. PMID 6992981  1
1980 Kimball PM, Brattain MG. Isolation of a Cellular Subpopulation from a Human Colonic Carcinoma Cell Line Cancer Research. 40: 1574-1579. PMID 6445228  1
1979 Brattain MG, Green C, Kimball PM, Marks M, Khaled M. Isoenzymes Of ß-Hexosaminidase From Normal Rat Colon And Colonic Carcinoma Cancer Research. 39: 4083-4090. PMID 476644  1
1979 Vogler LB, Crist WM, Vinson PC, Sarrif A, Brattain MG, Coleman MS. Philadelphia-chromosome-positive pre-B-cell leukemia presenting as blast crisis of chronic myelogenous leukemia Blood. 54: 1164-1170. PMID 315245  1
1979 Brattain MG, Kimball PM, Durant JR. Urinary hexosaminidase in patients with lung carcinoma Cancer. 44: 2269-2272. PMID 228842  1
1978 Pretlow TG, Kreisberg JI, Fine WD, Zieman GA, Brattain MG. Velocity sedimentation of organelles at low centrifugal force in an isokinetic gradient Biochemical Journal. 174: 303-307. PMID 697757  1
1978 Kimball PM, Brattain MG, Pitts AM. A soft-agar procedure measuring growth of human colonic carcinomas British Journal of Cancer. 37: 1015-1019. PMID 678422 DOI: 10.1038/bjc.1978.147  1
1978 Kimball PM, Brattain MG. A Comparison of Methods For The Isolation of Carcinoembryonic Antigen Cancer Research. 38: 619-623. PMID 203387  1
1977 Brattain MG, Pretlow TP, Pretlow TG. Cell fractionation of large bowel cancer Cancer. 40: 2479-2486. PMID 922689  1
1977 Pretlow TG, Brattain MG, Kreisberg JI. Separation and characterization of epithelial cells from prostates and prostatic carcinomas: a review Cancer Treatment Reports. 61: 153-156. PMID 872127  1
1977 Brattain MG, Kimball PM, Pretlow TG, Pitts AM. Partial purification of human colonic carcinoma cells by sedimentation British Journal of Cancer. 35: 850-857. PMID 871370 DOI: 10.1038/bjc.1977.128  1
1977 Helms SR, Brattain MG, Pretlow TG, Kreisberg JI. 'Prostatic acid phosphatase?'. A comparison of acid phosphatase activities in epithelial cells, granulocytes, monocytes, lymphocytes, and platelets purified by velocity sedimentation in isokinetic gradients of ficoll in tissue culture medium American Journal of Pathology. 88: 529-537. PMID 560800  1
1977 Kreisberg JI, Brattain MG, Pretlow TG. Studies on human hyperplastic prostates maintained in organ culture Investigative Urology. 15: 252-255. PMID 73529  1
1977 Brattain MG, Kimball PM, Pretlow TG, Marks ME. The interaction of N-acetylhexosaminidase with insolubilized concanavalin A. The Biochemical Journal. 163: 247-51. PMID 17397  1
1977 Brattain MG, Pretlow TG, Kimball PM. β-Hexosaminidase lsozymes in Human Colonic Carcinoma Cancer Research. 37: 731-735. PMID 13928  1
1977 Marks ME, Brattain MG, Pretlow TC, Kimball PM. The interaction of n-acetyl hexosaminidase with insolubilized concanavalin A Federation Proceedings. 36: No. 2314.  1
1976 Willson JKV, Pretlow TG, Zaremba JL, Brattain MG. Heterogeneity among preparations of crude trypsin used to disaggregate the human tonsil Immunological Communications. 30: 157-160. PMID 1248859  1
1976 Brattain MG, Marks ME, Pretlow TG. The purification of horseradish peroxidase by affinity chromatography on Sepharose--bound concanavalin A1,2. Analytical Biochemistry. 72: 346-52. PMID 942057 DOI: 10.1016/0003-2697(76)90540-6  1
1976 Brattain MG, Pretlow TG, Pittman JM, Weiler A. Variable binding of concanavalin a by human colon and colonic tumour British Journal of Cancer. 33: 659-663. PMID 938614 DOI: 10.1038/bjc.1976.104  1
1976 Brattain MG, Pittman JM, Pretlow TG. The use of glutaraldehyde conjugated horseradish peroxidase bovine serum albumin in the visualization of concanavalin A binding to tissue sections of human colonic tumor Laboratory Investigation. 35: 537-541. PMID 62892  1
1976 Brattain MG, Geer JC, Pretlow TG. The binding of insolubilized concanavalin A (Con A) to glycoproteins in the presence of 8M urea Federation Proceedings. 35.  1
1975 Brattain MG, Jones CM, Pittman JM, Pretlow TG. The purification of carcinoembryonic antigen by glutaraldehyde cross-linked concanavalin A Biochemical and Biophysical Research Communications. 65: 63-67. PMID 167772 DOI: 10.1016/S0006-291X(75)80061-1  1
1975 Brattain MG, Jones M, Pittman J, Pretlow TG. Purification of carcinoembryonic antigen by glutaraldehyde cross linked concanavalin A Federation Proceedings. 34.  1
1975 Pittman J, Brattain MG, Weiler A, Pretlow TG. Concanavalin A binding of human colon and colonic tumor Federation Proceedings. 34.  1
Show low-probability matches.